bupropion has been researched along with Alcohol Abuse in 19 studies
Bupropion: A propiophenone-derived antidepressant and antismoking agent that inhibits the uptake of DOPAMINE.
bupropion : An aromatic ketone that is propiophenone carrying a tert-butylamino group at position 2 and a chloro substituent at position 3 on the phenyl ring.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This is a double-blind placebo-controlled study of sustained-release bupropion as a smoking cessation aid in alcoholics undergoing treatment for their alcoholism." | 9.12 | Bupropion and nicotine patch as smoking cessation aids in alcoholics. ( Agrawal, S; Grant, KM; Kelley, SS; Meyer, JR; Romberger, DJ; Smith, LM, 2007) |
| "To evaluate the efficacy of bupropion for smoking cessation in smokers with a former history of major depression or alcoholism, and changes in depressive symptoms during smoking abstinence." | 9.09 | Efficacy of bupropion for smoking cessation in smokers with a former history of major depression or alcoholism. ( Croghan, IT; Glover, ED; Hayford, KE; Hurt, RD; Offord, KP; Patten, CA; Rummans, TA; Sachs, DP; Schroeder, DR, 1999) |
| "Smoking cessation trials of sustained-release bupropion (bupropion SR) were initially conducted in a general population of smokers who were motivated to quit smoking." | 8.81 | Use of sustained-release bupropion in specific patient populations for smoking cessation. ( Tonstad, S, 2002) |
| "This is a double-blind placebo-controlled study of sustained-release bupropion as a smoking cessation aid in alcoholics undergoing treatment for their alcoholism." | 5.12 | Bupropion and nicotine patch as smoking cessation aids in alcoholics. ( Agrawal, S; Grant, KM; Kelley, SS; Meyer, JR; Romberger, DJ; Smith, LM, 2007) |
| "To evaluate the efficacy of bupropion for smoking cessation in smokers with a former history of major depression or alcoholism, and changes in depressive symptoms during smoking abstinence." | 5.09 | Efficacy of bupropion for smoking cessation in smokers with a former history of major depression or alcoholism. ( Croghan, IT; Glover, ED; Hayford, KE; Hurt, RD; Offord, KP; Patten, CA; Rummans, TA; Sachs, DP; Schroeder, DR, 1999) |
| " In the United States there are medications available to treat tobacco use disorders (nicotine replacement, bupropion, and varenicline), alcohol use disorders (naltrexone and acamprosate), and opioid use disorders (methadone and buprenorphine)." | 4.93 | Pharmacotherapy for Substance Use Disorders. ( Klein, JW, 2016) |
| "Alcoholism and nicotine dependence share many neurobiological underpinnings; the presence of one drug can cause a person to crave the other." | 4.83 | Treating smoking dependence in depressed alcoholics. ( Ait-Daoud, N; Breland, AB; Johnson, BA; Lynch, WJ; Marzani-Nissen, GR; Penberthy, JK, 2006) |
| " Although alcoholism has received the most attention, nicotine, heroin, and cocaine have all been shown to be influenced by heredity." | 4.82 | Anticraving medications for relapse prevention: a possible new class of psychoactive medications. ( O'Brien, CP, 2005) |
| "Smoking cessation trials of sustained-release bupropion (bupropion SR) were initially conducted in a general population of smokers who were motivated to quit smoking." | 4.81 | Use of sustained-release bupropion in specific patient populations for smoking cessation. ( Tonstad, S, 2002) |
| "Treatment with bupropion SR among abstinent alcoholic smokers did not delay relapse or result in improved long-term smoking abstinence." | 2.74 | A randomized, controlled trial of bupropion sustained-release for preventing tobacco relapse in recovering alcoholics. ( Croghan, IT; Decker, PA; Hays, JT; Hurt, RD; Offord, KP; Patten, CA, 2009) |
| "Guidance on Major Depressive Disorder (MDD) treatment in those with comorbid Alcohol Use Disorder (AUD) is limited." | 1.91 | Treatment outcomes in major depressive disorder in patients with comorbid alcohol use disorder: A STAR*D analysis. ( Blumberger, DM; Daskalakis, ZJ; Jones, BDM; Le Foll, B; Sloan, ME; Tang, VM; Voineskos, D; Wang, G; Weissman, CR; Yu, D, 2023) |
| "fluoxetine treatment induced a long-lasting increase in alcohol consumption during relapse, an effect that was not observed in the case of bupropion treatment." | 1.51 | Bupropion, a possible antidepressant without negative effects on alcohol relapse. ( Alen, F; Antón, M; Arco, R; Ballesta, A; de Fonseca, FR; de Heras, RG; Nogueira-Arjona, R; Orio, L; Pavón, FJ; Ramírez-López, M; Romero-Sanchiz, P; Serrano, A; Suárez, J; Vargas, A, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (15.79) | 18.2507 |
| 2000's | 8 (42.11) | 29.6817 |
| 2010's | 4 (21.05) | 24.3611 |
| 2020's | 4 (21.05) | 2.80 |
| Authors | Studies |
|---|---|
| Tang, VM | 1 |
| Yu, D | 1 |
| Weissman, CR | 1 |
| Jones, BDM | 1 |
| Wang, G | 1 |
| Sloan, ME | 1 |
| Blumberger, DM | 1 |
| Daskalakis, ZJ | 1 |
| Le Foll, B | 1 |
| Voineskos, D | 1 |
| Deng, X | 1 |
| Shang, X | 1 |
| Guo, K | 1 |
| Zhou, L | 1 |
| Wang, Y | 1 |
| Wu, Y | 1 |
| Liang, S | 1 |
| E, F | 1 |
| Liu, W | 1 |
| Wang, Z | 1 |
| Li, X | 1 |
| Yang, K | 1 |
| Rábade-Castedo, C | 1 |
| de Granda-Orive, JI | 1 |
| Riesco-Miranda, JA | 1 |
| De Higes-Martínez, E | 1 |
| Ramos-Pinedo, Á | 1 |
| Cabrera-César, E | 1 |
| Signes-Costa Miñana, J | 1 |
| García Rueda, M | 1 |
| Pastor-Esplá, E | 1 |
| Jiménez-Ruiz, CA | 1 |
| Swinford-Jackson, SE | 1 |
| O'Brien, CP | 2 |
| Kenny, PJ | 1 |
| Vanderschuren, LJMJ | 1 |
| Unterwald, EM | 1 |
| Pierce, RC | 1 |
| Ballesta, A | 1 |
| Orio, L | 1 |
| Arco, R | 1 |
| Vargas, A | 1 |
| Romero-Sanchiz, P | 1 |
| Nogueira-Arjona, R | 1 |
| de Heras, RG | 1 |
| Antón, M | 1 |
| Ramírez-López, M | 1 |
| Serrano, A | 1 |
| Pavón, FJ | 1 |
| de Fonseca, FR | 1 |
| Suárez, J | 1 |
| Alen, F | 1 |
| Klein, JW | 1 |
| Hays, JT | 1 |
| Hurt, RD | 2 |
| Decker, PA | 1 |
| Croghan, IT | 2 |
| Offord, KP | 2 |
| Patten, CA | 2 |
| Saracino, MA | 1 |
| Marcheselli, C | 1 |
| Somaini, L | 1 |
| Gerra, G | 1 |
| De Stefano, F | 1 |
| Pieri, MC | 1 |
| Raggi, MA | 1 |
| Karam-Hage, M | 1 |
| Strobbe, S | 1 |
| Robinson, JD | 1 |
| Brower, KJ | 1 |
| Tonstad, S | 1 |
| Bagley, SC | 1 |
| Yaeger, D | 1 |
| Doran, CM | 1 |
| Duszynski, KM | 1 |
| Beilby, JJ | 1 |
| Mattick, RP | 1 |
| Ait-Daoud, N | 1 |
| Lynch, WJ | 1 |
| Penberthy, JK | 1 |
| Breland, AB | 1 |
| Marzani-Nissen, GR | 1 |
| Johnson, BA | 1 |
| Grant, KM | 1 |
| Kelley, SS | 1 |
| Smith, LM | 1 |
| Agrawal, S | 1 |
| Meyer, JR | 1 |
| Romberger, DJ | 1 |
| Nunes, EV | 1 |
| McGrath, PJ | 1 |
| Quitkin, FM | 1 |
| Litten, RZ | 1 |
| Allen, JP | 1 |
| Hayford, KE | 1 |
| Rummans, TA | 1 |
| Schroeder, DR | 1 |
| Glover, ED | 1 |
| Sachs, DP | 1 |
| Sullivan, MA | 1 |
| Covey, LS | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Pharmacologic Relapse Prevention for Alcoholic Smokers[NCT00000457] | Phase 2 | 195 participants (Actual) | Interventional | 1998-06-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
9 reviews available for bupropion and Alcohol Abuse
| Article | Year |
|---|---|
Efficacy and safety of antidepressants for smoking cessation: A systematic review and network meta-analysis.
Topics: Alcoholism; Antidepressive Agents; Bupropion; Humans; Network Meta-Analysis; Nortriptyline; Smoking; | 2023 |
Clinical Practice Guideline of Spanish Society of Pneumology and Thoracic Surgery (SEPAR) on Pharmacological Treatment of Tobacco Dependence 2023.
Topics: Adolescent; Alcoholism; Bupropion; Female; Humans; Nicotinic Agonists; Pregnancy; Pulmonary Medicine | 2023 |
Pharmacotherapy for Substance Use Disorders.
Topics: Age Factors; Alcohol Deterrents; Alcoholism; Antidepressive Agents; Buprenorphine; Bupropion; Drug T | 2016 |
Use of sustained-release bupropion in specific patient populations for smoking cessation.
Topics: Alcoholism; Body Weight; Bupropion; Delayed-Action Preparations; Depression; Dopamine Uptake Inhibit | 2002 |
Anticraving medications for relapse prevention: a possible new class of psychoactive medications.
Topics: Alcoholism; Behavior, Addictive; Bupropion; Cocaine-Related Disorders; Disulfiram; Humans; Naltrexon | 2005 |
Treating smoking dependence in depressed alcoholics.
Topics: Alcoholism; Antidepressive Agents; Bupropion; Clinical Trials as Topic; Cognitive Behavioral Therapy | 2006 |
Treating anxiety in patients with alcoholism.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Alcoholism; Antidepressive Agents; Anxiety Disorders | 1995 |
Medications for alcohol, illicit drug, and tobacco dependence. An update of research findings.
Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Buprenorphine; Bupropion; Forecasting; Humans; Methadyl | 1999 |
Nicotine dependence: the role for antidepressants and anxiolytics.
Topics: Alcoholism; Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Attention Deficit Disorde | 2002 |
5 trials available for bupropion and Alcohol Abuse
| Article | Year |
|---|---|
A randomized, controlled trial of bupropion sustained-release for preventing tobacco relapse in recovering alcoholics.
Topics: Adult; Aged; Alcoholism; Bupropion; Delayed-Action Preparations; Dopamine Uptake Inhibitors; Double- | 2009 |
Bupropion-SR for smoking cessation in early recovery from alcohol dependence: a placebo-controlled, double-blind pilot study.
Topics: Alcoholism; Bupropion; Delayed-Action Preparations; Dopamine Uptake Inhibitors; Double-Blind Method; | 2011 |
Hyponatremia associated with bupropion, a case verified by rechallenge.
Topics: Alcoholism; Antidepressive Agents, Second-Generation; Bipolar Disorder; Bupropion; Cocaine-Related D | 2005 |
Bupropion and nicotine patch as smoking cessation aids in alcoholics.
Topics: Administration, Cutaneous; Adult; Alcoholism; Bupropion; Community Health Services; Delayed-Action P | 2007 |
Efficacy of bupropion for smoking cessation in smokers with a former history of major depression or alcoholism.
Topics: Adult; Alcoholism; Antidepressive Agents, Second-Generation; Bupropion; Delayed-Action Preparations; | 1999 |
5 other studies available for bupropion and Alcohol Abuse
| Article | Year |
|---|---|
Treatment outcomes in major depressive disorder in patients with comorbid alcohol use disorder: A STAR*D analysis.
Topics: Alcoholism; Antidepressive Agents; Bupropion; Comorbidity; Depressive Disorder, Major; Humans; Treat | 2023 |
The Persistent Challenge of Developing Addiction Pharmacotherapies.
Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Bupropion; Central Nervous System Stimulants; Cocaine-R | 2021 |
Bupropion, a possible antidepressant without negative effects on alcohol relapse.
Topics: Alcohol Drinking; Alcoholism; Animals; Antidepressive Agents, Second-Generation; Bupropion; Dopamine | 2019 |
Simultaneous determination of disulfiram and bupropion in human plasma of alcohol and nicotine abusers.
Topics: Alcoholism; Bupropion; Chromatography, High Pressure Liquid; Disulfiram; Humans; Molecular Structure | 2010 |
Use of pharmacotherapies for the management of addictive behaviours in Australian clinical practice.
Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Australia; Bupropion; Dopamine Uptake Inhibitors; Femal | 2006 |